230 related articles for article (PubMed ID: 1888699)
21. Interleukin 1 alpha mediated inhibition of myogenic terminal differentiation: increased sensitivity of Ha-ras transformed cultures.
Harrington MA; Daub R; Song A; Stasek J; Garcia JG
Cell Growth Differ; 1992 Apr; 3(4):241-8. PubMed ID: 1325182
[TBL] [Abstract][Full Text] [Related]
22. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
23. Effects of v-src oncogene activation on radiation sensitivity in drug-sensitive and in multidrug-resistant rat fibroblasts.
Shimm DS; Miller PR; Lin T; Moulinier PP; Hill AB
Radiat Res; 1992 Feb; 129(2):149-56. PubMed ID: 1734444
[TBL] [Abstract][Full Text] [Related]
24. Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.
Han JW; Sadowski H; Young DA; Macara IG
Proc Natl Acad Sci U S A; 1990 May; 87(9):3373-7. PubMed ID: 2159148
[TBL] [Abstract][Full Text] [Related]
25. Expression of platelet-derived growth factor-independent phenotypes in BALB/c 3T3 cell variant with high susceptibility to chemically or physically induced neoplastic cell transformation: dissociation from activation of protein kinase C.
Tatsuka M; Owada MK; Mitsui H
Cancer Res; 1992 Aug; 52(15):4232-41. PubMed ID: 1638537
[TBL] [Abstract][Full Text] [Related]
26. Differences in inhibition by IDF45 (an inhibitory diffusible factor) of early RNA synthesis stimulation induced by pp60 v-src and various mitogens.
Delbe J; Villaudy J; Blat C; Desauty G; Golde A; Harel L
J Cell Physiol; 1990 Feb; 142(2):359-64. PubMed ID: 1689320
[TBL] [Abstract][Full Text] [Related]
27. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells.
Gangarosa LM; Sizemore N; Graves-Deal R; Oldham SM; Der CJ; Coffey RJ
J Biol Chem; 1997 Jul; 272(30):18926-31. PubMed ID: 9228072
[TBL] [Abstract][Full Text] [Related]
28. Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.
Scholz G; Felder MP; Hanafusa H
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2592-6. PubMed ID: 7535926
[TBL] [Abstract][Full Text] [Related]
29. [The regulation of protein kinase C activity in normal, immortalized and transformed rat fibroblasts].
Scholl-Engberts AD; Sokolova EN; Darieva ZA; Popov IuG; Pospelova TV; Gurevich VS
Tsitologiia; 1992; 34(5):110-7. PubMed ID: 1280871
[TBL] [Abstract][Full Text] [Related]
30. Functional dissection of transformation by c-Src and v-Src.
Oneyama C; Hikita T; Nada S; Okada M
Genes Cells; 2008 Jan; 13(1):1-12. PubMed ID: 18173743
[TBL] [Abstract][Full Text] [Related]
31. Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.
Sonoda H; Nishida K; Yoshioka T; Ohtani M; Sugita K
Oncogene; 1996 Jul; 13(1):143-9. PubMed ID: 8700540
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro.
Dent P; Reardon DB; Morrison DK; Sturgill TW
Mol Cell Biol; 1995 Aug; 15(8):4125-35. PubMed ID: 7623807
[TBL] [Abstract][Full Text] [Related]
33. Phorbol ester and bryostatin differentially regulate the hydrolysis of phosphatidylethanolamine in Ha-ras- and raf-oncogene-transformed NIH 3T3 cells.
Kiss Z; Rapp UR; Pettit GR; Anderson WB
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):505-9. PubMed ID: 2049075
[TBL] [Abstract][Full Text] [Related]
34. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.
Stacey DW; Roudebush M; Day R; Mosser SD; Gibbs JB; Feig LA
Oncogene; 1991 Dec; 6(12):2297-304. PubMed ID: 1766676
[TBL] [Abstract][Full Text] [Related]
35. Elevated prostaglandin H synthase gene expression in ras-transformed cells.
Gorman RR; Bienkowski MJ; Lin AH
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():73-6. PubMed ID: 1825590
[TBL] [Abstract][Full Text] [Related]
36. Altered H1 histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes.
Blackmore PF; Oakes SG; Somers KD
Oncogene; 1992 Oct; 7(10):2053-7. PubMed ID: 1408146
[TBL] [Abstract][Full Text] [Related]
37. Activation of (His)6-Raf-1 in vitro by partially purified plasma membranes from v-Ras-transformed and serum-stimulated fibroblasts.
Dent P; Sturgill TW
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9544-8. PubMed ID: 7937802
[TBL] [Abstract][Full Text] [Related]
38. Src tyrosine kinase inhibitor PP2 markedly enhances Ras-independent activation of Raf-1 protein kinase by phorbol myristate acetate and H2O2.
Lee M; Kim JY; Anderson WB
J Biol Chem; 2004 Nov; 279(47):48692-701. PubMed ID: 15356004
[TBL] [Abstract][Full Text] [Related]
39. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
40. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts.
Ahn JH; Ahn SK; Lee M
Biochem Biophys Res Commun; 2012 Jan; 417(2):857-63. PubMed ID: 22206679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
